Navigation Links
Sickle Cell Disease Tied to Cognitive Difficulties
Date:5/11/2010

Lowered blood oxygen levels may be to blame, researchers say

TUESDAY, May 11 (HealthDay News) -- Adults with sickle cell anemia are at increased risk for neurocognitive problems, which can affect their ability to cope with daily tasks such as work, managing their finances, taking medications, use of community resources, and socializing, a new study finds.

The research included 149 patients with sickle cell anemia (SCA), ages 19 to 55, and a control group of 47 healthy people. Both groups underwent MRI brain scans and tests of neuropsychological function.

Compared to the control group, the SCA patients had statistically significant lower average nonverbal function scores, and lower average scores for measures of processing speed, working memory, global cognitive function (which includes learning, memory and attention processes), and most measures of executive function (which includes the ability to control behavior, anticipate outcomes, adapt to change and make appropriate decisions).

The MRI scans revealed no brain structure differences between the sickle cell anemia patients and the controls. The neurocognitive problems in SCA patients appear to be due to anemia and age, the researchers said.

Adult patients with SCA who do not show symptoms of reasoning and thinking deficits are still at risk for problems in those areas, because their anemia may be causing cognitive impairment as a result of deficient oxygen in the blood that is undetectable by standard neuroimaging studies, according to Dr. Elliott P. Vichinsky, of Children's Hospital & Research Center in Oakland, Calif., and colleagues.

"Several practical steps can be taken. First, early identification of patients with difficulties on specific measures of neurocognitive function may allow these patients to enroll in and benefit from cognitive rehabilitation programs. Additionally, longitudinal studies are necessary to understand and evalu
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Blood stem-cell transplant regimen reverses sickle cell disease in adults
2. Bone Marrow Transplants May Cure Sickle Cell in Adults
3. Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
4. Statins Show Promise Against Sickle Cell
5. New approach to sickle-cell disease shows promise in mice
6. Swine Flu Can Batter Kids With Sickle Cell
7. New study finds barriers to pain treatment in children with sickle cell disease
8. Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease
9. Sickle Cell Disease Patients Seek Acute Pain Care Repeatedly
10. Low blood oxygen may lead to heart defects in children with sickle cell disease
11. New research identifies modifiable risk factors for heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... today launches the Knowledge & Resource Center, a collection ... care transitions and positively impact health outcomes. , By ... tools or resources that align with its mission to ... the promotion of public policy, and education and focused ... Knowledge & Resource Center serves as a mechanism by ...
(Date:4/1/2015)... LINCOLN, R.I. (PRWEB) April 01, 2015 After ... potholes. Driving over these potholes can lead to costly damage, ... your vehicle. , Amica is sharing the following suggestions from ... have plenty of tread and be inflated to the manufacturer’s ... change in vehicle handling, excessive vibration and uneven tire wear ...
(Date:4/1/2015)... April 01, 2015 The Pennsylvania Court ... lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled a meeting ... the Philadelphia Court of Common Pleas, the meeting will ... Hall. Court records indicate that the proceeding will address ... of Risperdal users who experienced gynecomastia (male breast growth) ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 EAGAN, Minn. ... Minnesota and its family of companies (Blue Cross) today ... out the year with net income of $61.5 million, ... losses. The organization reported a net operating loss of ... a negative operating margin of one-tenth of one percent ...
(Date:4/1/2015)... Manistee, Michigan (PRWEB) April 01, 2015 ... visit Best Drug Rehabilitation’s blog, where the latest post ... of last month’s observation of Teen Dating Violence Awareness ... toolkit on this growing problem to help parents identify ... their romantic interest that might involve drugs or alcohol. ...
Breaking Medicine News(10 mins):Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2
... for female clinicians, including intelligent innovations that redefine the way women ... and first-of-their-kind enhancements, Medelita sets a new standard for quality, comfort, ... the U.S. alone wearing scrubs and lab coats to work. ... ...
... 12 Former Speaker of the,House and Founder of the ... hearing of the passing of Tony Snow:, "With the ... loving,father, and a very talented journalist., "Tony was at ... knowledge,of politics and government had been greatly expanded by his ...
... tumor suppressor instead , , FRIDAY, July 11 (HealthDay News) -- ... cancer cells in lab cultures was, until recently, thought to ... have found that a gene called TCF7L2 is active in ... malfunction in a gene. As a result, researchers suspected TCF7L2 ...
... President Sirleaf while part of Mercy Ships Crew , ... ... from a week-long international humanitarian mission to support Mercy Ships, his ... training camp with an additional sense of purpose knowing that he's ...
... Emageon Inc.,(Nasdaq: EMAG ), a leader in ... and imaging facilities,announced today that the Strategic Alternatives ... and Company as Lead Advisor and SunTrust,Robinson Humphrey ... evaluates all,strategic options available to the company., ...
... July 11 In a letter to the,Senate, ... policymakers to address critical shortfalls in legislation that ... With the Senate,poised to vote on a five-year, ... policymakers to "both set and correct policies based,on ...
Cached Medicine News:Health News:Medelita Introduces A Breakthrough In Healthcare Uniforms For Women 2Health News:Medelita Introduces A Breakthrough In Healthcare Uniforms For Women 3Health News:Newt Gingrich Statement on the Loss of Tony Snow 2Health News:Redskins' Draft Pick Malcolm Kelly Energized By Trip To Mercy Ship In Liberia 2Health News:Redskins' Draft Pick Malcolm Kelly Energized By Trip To Mercy Ship In Liberia 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 2Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 5
(Date:4/1/2015)... 1, 2015 Trinity Biotech plc (Nasdaq: ... of diagnostic products for the point-of-care and clinical ... Limited, its wholly-owned subsidiary (the "Issuer"), intends to ... million aggregate principal amount of Exchangeable Senior Notes ... institutional buyers pursuant to Rule 144A under the ...
(Date:4/1/2015)... 1, 2015  Pittman Motors has significantly expanded ... PLG42K, PLG42S, PLG52, and PLG63 planetary gearboxes. These ... brushless DC motors and complement Pittman,s existing spur ... 35 standard motor-gearbox family combinations to the Pittman ... high torque loads with excellent efficiency and are ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April 1, ... ) announces that it has signed a definitive ... device company that develops, manufactures and sells minimally ... drainage of targeted areas within the gastrointestinal tract. ... The Xlumena portfolio includes the ...
Breaking Medicine Technology:Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Pittman Motors Expands PLG Planetary Gearbox Offering 2Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5
... Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: ... specializing in the development, manufacturing, and marketing of ... that Shanghai Celgen Bio-Pharmaceutical Co., Ltd. ("Shanghai Celgen") ... interest, has received new drug registration approval for ...
... Cempra Pharmaceuticals, a developer of differentiated antibiotics, ... (IV) solithromycin demonstrates excellent tolerability and ... up to 800 mg.  Oral administration of solithromycin ... 1 studies.  The presentation will be at the ...
Cached Medicine Technology:Simcere Announces Recent Progress of Qiangke's Registration 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 3Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 4Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 5Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 6Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 7
... monitors and controls patient temperature primarily in ... surgery, trauma, or other medical conditions. The ... provided from a patient temperature probe. Circulating ... and 42C (107.6F) to achieve a preset ...
... The Littmann Electronic Stethoscope Model 4100WS ... (ANR) technology allowing you to reduce ambient ... without eliminating critical body sounds. Three frequency ... lung, and other body sounds: Bell (20-200 ...
... The OmniMD orthopedics EMR addresses the vast ... specific EMR includes clinically-defined templates for common ... review of systems. The system also includes ... are used to capture accurate charges and ...
Intrinsic Dual Chamber ICD With MVP Mode (Managed Ventricular Pacing). MVP promotes intrinsic conduction and is clinically proven to reduce unnecessary right ventricular (RV) pacing to approximately...
Medicine Products: